Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cullinan Therapeutics (CGEM) Tax Provisions (2022 - 2023)

Historic Tax Provisions for Cullinan Therapeutics (CGEM) over the last 2 years, with Q4 2023 value amounting to -$14.1 million.

  • Cullinan Therapeutics' Tax Provisions fell 65157.0% to -$14.1 million in Q4 2023 from the same period last year, while for Dec 2023 it was -$14.1 million, marking a year-over-year decrease of 13356.95%. This contributed to the annual value of $117000.0 for FY2024, which is 10082.85% up from last year.
  • Latest data reveals that Cullinan Therapeutics reported Tax Provisions of -$14.1 million as of Q4 2023, which was down 65157.0% from -$1.9 million recorded in Q4 2022.
  • In the past 5 years, Cullinan Therapeutics' Tax Provisions ranged from a high of $66.1 million in Q2 2022 and a low of -$19.6 million during Q1 2022